Companies / Cumberland Pharmaceuticals Inc. / Activity
Activity — Cumberland Pharmaceuticals Inc.
12 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Krogulski Kenneth Director | Grant | Common Stock | $5.0K | +2K +0.61% | 298,338 1.99% of shares | low |
| Mar 18, 2026 | Young Caroline Director | Grant | Common Stock | $5.0K | +2K +5.40% | 35,109 0.23% of shares | low |
| Mar 18, 2026 | Galante Joseph C Director | Grant | Common Stock | $5.0K | +2K +2.91% | 63,656 0.42% of shares | low |
| Mar 18, 2026 | Jones James Director | Grant | Common Stock | $5.0K | +2K +3.99% | 46,863 0.31% of shares | low |
| Mar 18, 2026 | Brown Martin S JR Director | Grant | Common Stock | $5.0K | +2K +21.18% | 10,300 0.07% of shares | low |
| Mar 18, 2026 | Krogulski Kenneth Director | Grant | Common Stock | $11.2K | +4K +1.34% | 302,338 2.02% of shares | low |
| Mar 16, 2026 | A.J. Kazimi CEO | Other | Common Stock | $17.9K | -6K -0.10% | 5,695,310 38.01% of shares | low |
| Mar 18, 2026 | Herman James L Executive | Grant | Options (right to buy) | — | +3K +13.51% | 21,000 0.14% of shares | low |
| Mar 18, 2026 | Anthony Todd M. Executive | Grant | Options (right to buy) | — | +3K +16.67% | 21,000 0.14% of shares | low |
| Mar 18, 2026 | Bitterman Chris T. Executive | Grant | Options (right to buy) | — | +3K +18.75% | 19,000 0.13% of shares | low |
| Mar 18, 2026 | Hamm John M. Executive | Grant | Options (right to buy) | — | +3K +19.67% | 18,250 0.12% of shares | low |
| Mar 18, 2026 | A.J. Kazimi CEO | Grant | Options (right to buy) | — | +100K +21.37% | 568,000 3.79% of shares | low |